Summary of obatoclax clinical activity in 13 patients with relapsed classical Hodgkin lymphoma
| Patient no. . | Age, y . | Sex . | No. of prior regimen . | Prior transplantation . | Treatment duration, wk . | Best response . |
|---|---|---|---|---|---|---|
| 1 | 37 | male | 7 | yes | 24 | stable disease |
| 2 | 25 | female | 5 | yes | 8 | stable disease |
| 3 | 33 | female | 8 | yes | 7 | progression |
| 4 | 51 | male | 4 | yes | 98 | stable disease |
| 5 | 58 | male | 3 | no | 8 | not evaluated |
| 6 | 37 | male | 5 | yes | 5 | progression |
| 7 | 42 | male | 11 | yes | 7 | progression |
| 8 | 60 | male | 7 | yes | 16 | stable disease |
| 9 | 39 | female | 7 | yes | 4 | not evaluated |
| 10 | 50 | male | 5 | yes | 8 | progression |
| 11 | 25 | male | 6 | yes | 16 | stable disease |
| 12 | 27 | male | 5 | no | 8 | progression |
| 13 | 34 | male | 8 | no | 3 | not evaluated |
| Patient no. . | Age, y . | Sex . | No. of prior regimen . | Prior transplantation . | Treatment duration, wk . | Best response . |
|---|---|---|---|---|---|---|
| 1 | 37 | male | 7 | yes | 24 | stable disease |
| 2 | 25 | female | 5 | yes | 8 | stable disease |
| 3 | 33 | female | 8 | yes | 7 | progression |
| 4 | 51 | male | 4 | yes | 98 | stable disease |
| 5 | 58 | male | 3 | no | 8 | not evaluated |
| 6 | 37 | male | 5 | yes | 5 | progression |
| 7 | 42 | male | 11 | yes | 7 | progression |
| 8 | 60 | male | 7 | yes | 16 | stable disease |
| 9 | 39 | female | 7 | yes | 4 | not evaluated |
| 10 | 50 | male | 5 | yes | 8 | progression |
| 11 | 25 | male | 6 | yes | 16 | stable disease |
| 12 | 27 | male | 5 | no | 8 | progression |
| 13 | 34 | male | 8 | no | 3 | not evaluated |